Home600645 • SHA
add
Vcanbio Cell & Gene Engineering Corp Ltd
Previous close
¥21.80
Day range
¥21.61 - ¥22.05
Year range
¥15.42 - ¥25.40
Market cap
10.08B CNY
Avg Volume
14.71M
P/E ratio
113.96
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 350.79M | -11.86% |
Operating expense | 202.95M | -7.84% |
Net income | 28.03M | -30.18% |
Net profit margin | 7.99 | -20.81% |
Earnings per share | — | — |
EBITDA | 72.19M | — |
Effective tax rate | 29.55% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.55B | 2.06% |
Total assets | 5.25B | -2.19% |
Total liabilities | 1.57B | -1.51% |
Total equity | 3.68B | — |
Shares outstanding | 467.17M | — |
Price to book | 2.81 | — |
Return on assets | 1.75% | — |
Return on capital | 2.43% | — |
Cash Flow
Net change in cash
(CNY) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 28.03M | -30.18% |
Cash from operations | 46.40M | 116.56% |
Cash from investing | -10.92M | 46.43% |
Cash from financing | -7.72M | 87.93% |
Net change in cash | 26.42M | 143.21% |
Free cash flow | -12.36M | — |
About
Founded
1992
Website
Employees
2,209